Phase 5 : La coordination-dissociation

Araújo, D.D. (2003). A expressão de um segmento estrutural do domínio cauda das

miosinas Va eVc, em células de melanoma murino, afeta a viabilidade celular.

Dissertação de Mestrado. Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.

Asselin, B.L. (1999). The three asparaginases. Comparative pharmacology and optimal

use in childhood leukemia. Adv Exp Med Biol. 457:621-9.

Bahler, M. (2000). Are class III and class IX myosins motorized signalling molecules? Biochim Biophys Acta. 1496:52-9.

Baselga, J., and Albanell, J.. (2001). Mechanism of action of anti-HER2 monoclonal

antibodies. Ann Oncol. 12 Suppl 1:S35-41

Berg, J.S., B.C. Powell, and R.E. Cheney. (2001). A millennial myosin census. Mol Biol Cell. 12:780-94.

Borges, A.C.. (2007). Fragmento da miosina Va induz apoptose em células de

melanoma e carcinoma. Dissertação de mestrado. Faculdade de Medicina de

Ribeirão Preto, Universidade de São Paulo.

Cemazar, M., G. Sersa, J. Wilson, G.M. Tozer, S.L. Hart, A. Grosel, and G.U. Dachs. (2002). Effective gene transfer to solid tumors using different nonviral gene

delivery techniques: electroporation, liposomes, and integrin-targeted vector.

Cancer Gene Ther. 9:399-406.

Chopin V, Toillon RA, Jouy N, Le Bourhis X. (2002). Sodium butyrate induces P53-

independent, Fas-mediated apoptosis in MCF-7 human breast cancer cells. Br J

Pharmacol 2002, 135,79–86.

Emanuele S, D'Anneo A, Bellavia G, Vassallo B, Lauricella M, De Blasio A, Vento R, Tesoriere G. (2004). Sodium butyrate induces apoptosis in human hepatoma

cells by a mitochondria/caspase pathway, associated with degradation of beta- catenin, pRb and Bcl-XL. Eur J Cancer. 2004 Jun;40(9):1441-52.

__________________________________________________________________________Referências Bibliográficas

82

Espreafico, E.M., Cheney, R.E., Matteoli, M., Nascimento, A.A., De Camilli, P.V., Larson, R.E., and Mooseker, M.S. (1992). Primary structure and cellular

localization of chicken brain myosin-V (p190), an unconventional myosin with calmodulin light chains. The Journal of cell biology 119, 1541-1557.

Franken NA, Rodermond HM, Stap J, Haveman J, van Bree C.(2006). Clonogenic

assay of cells in vitro. Nat Protoc. 2006;1(5):2315-9.

Fidler, I.J. (1973). Selection of successive tumour lines for metastasis. Nature: New biology 242, 148-149.

Franken NA, Rodermond HM, Stap J, Haveman J, van Bree C. (2006). Clonogenic

assay of cells in vitro. Nat Protoc.;1(5):2315-9.

Froidevaux, S., and Eberle, A.N.. (2002). Somatostatin analogs and radiopeptides in

cancer therapy. Biopolymers. 66:161-83.

Gallia, G.L., and K. Khalili. (1998). Evaluation of an autoregulatory tetracycline

regulated system. Oncogene. 16:1879-84.

Gossen, M., and H. Bujard. (2002). Studying gene function in eukaryotes by conditional

gene inactivation. Annu Rev Genet. 36:153-73.

Hattori Y, Ding WX, Maitani Y. (2007). Highly efficient cationic hydroxyethylated

cholesterol-based nanoparticle-mediated gene transfer in vivo and in vitro in prostate carcinoma PC-3 cells. J Control Release. 2007 Jul 16;120(1-2):122-30. Epub 2007 Apr 25.

Harries, M., and Smith, I.. (2002). The development and clinical use of trastuzumab

(Herceptin). Endocr Relat Cancer. 9:75-85.

Hernandez A, Thomas R, Smith F, Sandberg J, Kim S, Chung DH, Evers BM. (2001).

Butyrate sensitizes human colon cancer cells to TRAIL-mediated apoptosis.

__________________________________________________________________________Referências Bibliográficas

INSTITUTO NACIONAL DO CÂNCER. Estimativas de Incidência e Mortalidade. http://www.inca.gov.br. Página acessada em maio de 2012.

Izidoro-Toledo, T.C.I. (2006). Interferência no complexo miosina Va/DLC2/BMF revela

um novo mecanismo para a indução de apoptose em células de melanoma.

Tese de Doutorado. Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.

Kamitani H, Taniura S, Watanabe K, Sakamoto M, Watanabe T, Eling T. (2002).

Histone acetylation may suppress human glioma cell proliferation when p21 WAF/Cip1 and gelsolin are induced. Neuro-oncology 2002, 4, 95–101.

Kelly WK, O'Connor OA, Marks PA. (2002). Histone deacetylase inhibitors: from target

to clinical trials. Expert Opin Investig Drugs. 2002 Dec;11(12):1695-713.

Krendel M, Mooseker MS. (2005). Myosins: tails (and heads) of functional diversity. Physiology (Bethesda). 2005 Aug;20:239-51.

Hódi Z, Németh AL, Radnai L, Hetényi C, Schlett K, Bodor A, Perczel A, Nyitray L. (2006) Alternatively spliced exon B of myosin Va is essential for binding the tail-

associated light chain shared by dynein. Biochemistry. 2006 Oct

17;45(41):12582-95.

Lavergne, E., C. Combadiere, M. Iga, A. Boissonnas, O. Bonduelle, M. Maho, P. Debre, and B. Combadiere. (2004). Intratumoral CC chemokine ligand 5

overexpression delays tumor growth and increases tumor cell infiltration. J

Immunol. 173:3755-62.

Lei, K., and R.J. Davis. (2003). JNK phosphorylation of Bim-related members of the

Bcl2 family induces Bax-dependent apoptosis. Proc Natl Acad Sci U S A.

100:2432-7.

Lois, C., E.J. Hong, S. Pease, E.J. Brown, and D. Baltimore. (2002). Germline

transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science. 295:868-72.

__________________________________________________________________________Referências Bibliográficas

84

Lyng, H., A. Skretting, and E.K. Rofstad. (1992). Blood flow in six human melanoma

xenograft lines with different growth characteristics. Cancer Res. 52:584-92.

Lu, J., Q. Sun, X. Chen, H. Wang, Y. Hu, and J. Gu. 2005. Identification of dynein light

chain 2 as an interaction partner of p21-activated kinase 1. Biochem Biophys

Res Commun. 331:153-8.

Marshall, H. (2001). Anti-CD20 antibody therapy is highly effective in the treatment of

follicular lymphoma. Trends Immunol. 22:183-4.

Miller DG, Miller AD.(1992). Tunicamycin treatment of CHO cells abrogates multiple

blocks to retrovirus infection, one of which is due to a secreted inhibitor. J Virol.

1992 Jan;66(1):78-84.

Mills, J.C., Stone, N.L., and Pittman, R.N. (1999). Extranuclear apoptosis. The role of

the cytoplasm in the execution phase. The Journal of cell biology 146, 703-708.

Mitsudomi T. (2010). Advances in target therapy for lung cancer. Jpn J Clin Oncol. 2010 Feb;40(2):101-6. Epub 2009 Dec 23.

Miyoshi, H., U. Blomer, M. Takahashi, F.H. Gage, and I.M. Verma. (1998). Development of a self-inactivating lentivirus vector. J Virol. 72:8150-7.

Mohiuddin I, Cao X, Fang B, Nishizaki M, Smythe WR. (2001). Significant

augmentation of pro-apoptotic gene therapy by pharmacologic Bcl-XL down- regulation in mesothelioma. Cancer Gene Ther 2001, 8, 547–554.

Naisbitt, S., Valtschanoff, J., Allison, D.W., Sala, C., Kim, E., Craig, A.M., Weinberg, R.J., and Sheng, M. (2000). Interaction of the postsynaptic density-95/guanylate

kinase domain-associated protein complex with a light chain of myosin-V and dynein. J Neurosci 20, 4524-4534.

Pang, S., M.K. Kang, S. Kung, D. Yu, A. Lee, B. Poon, I.S. Chen, B. Lindemann, and N.H. Park. (2001). Anticancer effect of a lentiviral vector capable of expressing

__________________________________________________________________________Referências Bibliográficas

Peixoto PM, Ryu SY, Kinnally KW. (2005). Mitochondrial ion channels as therapeutic

targets. FEBS Lett. 2010 May 17;584(10):2142-52. Epub 2010 Feb 20.

Peixoto PM, Lue JK, Ryu SY, Wroble BN, Sible JC, Kinnally KW. (2011). Mitochondrial

apoptosis-induced channel (MAC) function triggers a Bax/Bak-dependent bystander effect. Am J Pathol. 2011 Jan;178(1):48-54. Epub 2010 Dec 23.

Puthalakath, H., A. Villunger, L.A. O'Reilly, J.G. Beaumont, L. Coultas, R.E. Cheney, D.C. Huang, and A. Strasser. (2001). Bmf: a proapoptotic BH3-only protein

regulated by interaction with the myosin V actin motor complex, activated by anoikis. Science. 293:1829-32

Riond JL, Riviere JE (1988). Pharmacology and toxicology of doxycycline. Vet Hum Toxicol. 1988 Oct;30(5):431-43

Soldatenkov VA, Prasad S, Voloshin Y, Dritschilo A. (1998) Sodium butyrate induces

apoptosis and accumulation of ubiquitinated proteins in human breast carcinoma cells. Cell Death Diff, 5, 307–312.

Towbin H, Staehelin T, Gordon J. (1979) Electrophoretic transfer of proteins from

polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Biotechnology. 1992;24:145-9.

Vadlamudi, R.K., R. Bagheri-Yarmand, Z. Yang, S. Balasenthil, D. Nguyen, A.A. Sahin, P. den Hollander, and R. Kumar. (2004). Dynein light chain 1, a p21-activated

kinase 1-interacting substrate, promotes cancerous phenotypes. Cancer Cell.

5:575-85.

Wang XM, Li J, Evers BM. Inhibition of proliferation, invasion and adhesion of liver

cancer cells by 5-azacytidine and butyrate. Anticancer Res (1999), 19, 2901–

2906.

Waxman, D.J., and P.S. Schwartz. (2003). Harnessing apoptosis for improved

anticancer gene therapy. Cancer Res. 63:8563-72.

Yang, J., S.A. Mani, J.L. Donaher, S. Ramaswamy, R.A. Itzykson, C. Come, P. Savagner, I. Gitelman, A. Richardson, and R.A. Weinberg. (2004). Twist, a

__________________________________________________________________________Referências Bibliográficas

86

master regulator of morphogenesis, plays an essential role in tumor metastasis.

Cell. 117:927-39.

Sumimoto H, Yamagata S, Shimizu A, Miyoshi H, Mizuguchi H, Hayakawa T, Miyagishi M, Taira K, Kawakami Y. (2005) Gene therapy for human small-cell lung

carcinoma by inactivation of Skp-2 with virally mediated RNA interference.

Gene Ther. Jan;12(1):95-100.

Zhu, Z., T. Zheng, C.G. Lee, R.J. Homer, and J.A. Elias. (2002). Tetracycline-controlled

transcriptional regulation systems: advances and application in transgenic animal modeling. Semin Cell Dev Biol. 13:121-8.